These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6660505)

  • 1. High-performance liquid chromatographic analysis on radial compression column of the neurotoxic tri-o-cresyl phosphate and metabolites.
    Nomeir AA; Abou-Donia MB
    Anal Biochem; 1983 Dec; 135(2):296-303. PubMed ID: 6660505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of [14C]tri-o-cresyl phosphate and its metabolites in various tissues of the male cat following a single dermal application.
    Nomeir AA; Abou-Donia MB
    Drug Metab Dispos; 1984; 12(6):705-11. PubMed ID: 6150819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the metabolism of the neurotoxic tri-o-cresyl phosphate. Synthesis and identification by infrared, proton nuclear magnetic resonance and mass spectrometry of five of its metabolites.
    Nomeir AA; Abou-Donia MB
    Toxicology; 1986 Jan; 38(1):1-13. PubMed ID: 3942005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the metabolism of the neurotoxic tri-o-cresyl phosphate. Distribution, excretion, and metabolism in male cats after a single, dermal application.
    Nomeir AA; Abou-Donia MB
    Toxicology; 1986 Jan; 38(1):15-33. PubMed ID: 3942008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption, distribution, excretion and metabolism of a single oral dose of [14C]tri-o-cresyl phosphate (TOCP) in the male rat.
    Abou-Donia MB; Nomeir AA; Bower JH; Makkawy HA
    Toxicology; 1990 Dec; 65(1-2):61-74. PubMed ID: 2274970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and metabolism of a single subneurotoxic oral dose of tri-o-cresyl phosphate in hens.
    Suwita E; Abou-Donia MB
    Arch Toxicol; 1990; 64(3):237-41. PubMed ID: 2372235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition, elimination, and metabolism of tri-o-cresyl phosphate following daily oral administration in Fischer 344 male rats.
    Somkuti SG; Abou-Donia MB
    Arch Toxicol; 1990; 64(7):572-9. PubMed ID: 2073130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of neurotoxic effects of tri-cresyl phosphates (TCPs) and cresyl saligenin phosphate (CBDP) using a combination of in vitro techniques.
    Hausherr V; Schöbel N; Liebing J; van Thriel C
    Neurotoxicology; 2017 Mar; 59():210-221. PubMed ID: 27288108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, distribution, and elimination of a single oral dose of [14C]tri-o-cresyl phosphate in hens.
    Abou-Donia MB; Suwita E; Nomeir AA
    Toxicology; 1990 Mar; 61(1):13-25. PubMed ID: 2315948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of ortho-cresyl phosphate adducts to butyrylcholinesterase in human serum by immunomagnetic-UHPLC-MS/MS.
    Johnson D; Carter MD; Crow BS; Isenberg SL; Graham LA; Erol HA; Watson CM; Pantazides BG; van der Schans MJ; Langenberg JP; Noort D; Blake TA; Thomas JD; Johnson RC
    J Mass Spectrom; 2015 Apr; 50(4):683-92. PubMed ID: 26149113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of Sertoli and Leydig cells in the testicular toxicity of tri-o-cresyl phosphate.
    Chapin RE; Phelps JL; Somkuti SG; Heindel JJ; Burka LT
    Toxicol Appl Pharmacol; 1990 Jul; 104(3):483-95. PubMed ID: 2385838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicokinetics of [14C]-saligenin cyclic-o-tolyl phosphate in anesthetized male F-344 rats.
    Burka LT; Chapin RE
    Reprod Toxicol; 1993; 7(1):81-6. PubMed ID: 8448420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of tricresyl phosphates and determination of tri-o-cresyl phosphate in edible oils.
    Krishnamurthy MN; Rajalakshmi S; Kapur OP
    J Assoc Off Anal Chem; 1985; 68(6):1074-6. PubMed ID: 4086427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human cytochrome P450s involved in the bioactivation of tri-ortho-cresyl phosphate (ToCP).
    Reinen J; Nematollahi L; Fidder A; Vermeulen NP; Noort D; Commandeur JN
    Chem Res Toxicol; 2015 Apr; 28(4):711-21. PubMed ID: 25706813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cyclic metabolites of isopropylated phenyl phosphates in rabbit bile.
    Yang SM; Thieme RA; von Meyerinck L; Benthe HF
    Biomed Environ Mass Spectrom; 1990 Sep; 19(9):573-6. PubMed ID: 2224186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the delayed neurotoxic potential and potency for a series of triaryl phosphates using an in vitro test with metabolic activation.
    Sprague GL; Castles TR
    Neurotoxicology; 1985; 6(1):79-86. PubMed ID: 3873039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of tri-o-cresyl phosphate and metabolites on rat Sertoli cell function in primary culture.
    Chapin RE; Phelps JL; Burka LT; Abou-Donia MB; Heindel JJ
    Toxicol Appl Pharmacol; 1991 Apr; 108(2):194-204. PubMed ID: 1902005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electromyographic, neuropathologic, and functional correlates in the cat as the result of tri-o-cresyl phosphate delayed neurotoxicity.
    Abou-Donia MB; Trofatter LP; Graham DG; Lapadula DM
    Toxicol Appl Pharmacol; 1986 Mar; 83(1):126-41. PubMed ID: 3952742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive tract lesions resulting from subchronic administration (63 days) of tri-o-cresyl phosphate in male rats.
    Somkuti SG; Lapadula DM; Chapin RE; Lamb JC; Abou-Donia MB
    Toxicol Appl Pharmacol; 1987 Jun; 89(1):49-63. PubMed ID: 3590188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurologic manifestations of tri-O-cresyl phosphate delayed neurotoxicity in cats.
    Abou-Donia MB; Jensen DN; Lapadula DM
    Neurobehav Toxicol Teratol; 1983; 5(4):431-42. PubMed ID: 6646317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.